Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 10/18/23

Gastrointestinal (GI) SPOREs

SPOREs in GI cancers focus on translational research in the gastrointestinal system and include cancers of the colon, rectum, stomach, esophagus, small intestine, liver, gallbladder and other digestive organs. Over 315,000 newly diagnosed cases of cancer in the digestive system and 162,000 deaths are expected in the United States in the year 2023, the American Cancer Society estimates. Colorectal and colon cancers are particularly prevalent and represent 8% of all new cancer cases in the U.S. They are expected to cause 46,050 deaths in the United States in 2023. Currently, GI SPOREs focus on cancers of the colon, rectum, esophagus, stomach, liver, and pancreas, which account for the majority of new diagnoses.